Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Our therapeutics are founded on the novel scientific discovery of a pathway, the IGFBP3/TMEM219 axis, found to be involved in stem cell apoptosis in the gut, as well as pancreatic and other tissues.

List your booth number for exhibitions, ask us